Want to track SGMO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sangamo Therapeutics Inc. (SGMO) Statistics
Valuation metrics
Market Cap 30.66M
Enterprise value 22.4M
Trailing P/E (ttm) -0.2
Forward P/E 9.58
PEG ratio 0.01
Price/Sales (ttm) 0.89
Price/Book (mrq) -1.52
Enterprise Value/Revenue 0.65
Enterprise Value/EBITDA -0.19
Overview
Shares outstanding 350.69M
Float 406.77M
Shares short 42.88M
% Held by insiders 0.02%
% Held by institutions 0.15%
Average volume (10 days) 3.74M
Average volume (90 days) 10.45M
Price summary
52-Week low 0.03
52-Week high 0.77
Beta 1.5
50-Day moving average 0.09
200-Day moving average 0.29
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -3.57%
Operating margin -3.19%
Operational effectiveness
Return on assets -2.06%
Return on equity 66.86%
Income Statement
Revenue (ttm) 39.55M
Revenue per share (ttm) 0.09
Quarterly revenue growth (yoy) 0.88%
Gross profit (ttm) -73.12M
EBITDA -104.04M
Net income to common (ttm) -122.93M
Diluted EPS (ttm) -0.32
Quarterly earnings growth (yoy) 0.88%
Balance Sheet
Total cash (mrq) 20.95M
Total cash per share (mrq) 0.07
Total debt (mrq) 26.8M
Total Debt/Equity (mrq) -1.02
Current ratio (mrq) 0.7%
Book value per share (mrq) -0.05
Cash Flow
Cash flow statement -97.21M
Levered free cash flow (LFCF) -56.76M
